Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Primary sclerosing cholangitis (PSC) is a rare condition that can be associated with inflammatory bowel disease (IBD). The aim of this study was to evaluate PSC and its association with IBD in children.Methods: We retrospectively enrolled 13 pediatric patients (＜18 years) with PSC treated at Asan Medical Center between June 1989 and December 2013. Clinical findings and long-term outcomes were investigated. During the same period, the incidence of PSC among IBD patients was evaluated among 600 Crohn disease (CD) and 210 ulcerative colitis (UC) patients.Results: All 13 study patients diagnosed with PSC also presented with IBD. Eleven boys and two girls with a median age of 15.0 years old (9.0-17.8 years) were included. The cumulative incidence of PSC for UC was 5.7% (12 of 210) and 0.2% for CD (1 of 600), respectively. PSC occurred during follow-up for IBD for five patients (38.5%) whereas, IBD developed during follow-up for PSC for two patients (15.4%), and was diagnosed during the initial work-up for PSC for 6 patients (46.2%). For the 77.3 month median follow-up period, 9/13 patients (69.2%), neither the clinical symptoms nor blood test results worsened. Two cases (15.4%) developed liver cirrhosis and underwent liver transplantation. Among 13 PSC patients with IBD, two (15.4%) developed colorectal cancer, and no one developed cholangiocarcinoma. Conclusion: All patients with PSC in this study had associated IBD. The incidence of PSC was not rare compared to reports in adults. PSC should be considered during the management of IBD and vice versa in children.
Abstract
Purpose: Primary sclerosing cholangitis (PSC) is a rare condition that can be associated with inflammatory bowel disease (IBD). The aim of this study was to evaluate PSC and its association with IBD in children.Methods: We retrospectively enrolled 13 pediatric patients (＜18 years) with PSC treated at Asan Medical Center between June 1989 and December 2013. Clinical findings and long-term outcomes were investigated. During the same period, the incidence of PSC among IBD patients was evaluated among 600 Crohn disease (CD) and 210 ulcerative colitis (UC) patients.Results: All 13 study patients diagnosed with PSC also presented with IBD. Eleven boys and two girls with a median age of 15.0 years old (9.0-17.8 years) were included. The cumulative incidence of PSC for UC was 5.7% (12 of 210) and 0.2% for CD (1 of 600), respectively. PSC occurred during follow-up for IBD for five patients (38.5%) whereas, IBD developed during follow-up for PSC for two patients (15.4%), and was diagnosed during the initial work-up for PSC for 6 patients (46.2%). For the 77.3 month median follow-up period, 9/13 patients (69.2%), neither the clinical symptoms nor blood test results worsened. Two cases (15.4%) developed liver cirrhosis and underwent liver transplantation. Among 13 PSC patients with IBD, two (15.4%) developed colorectal cancer, and no one developed cholangiocarcinoma. Conclusion: All patients with PSC in this study had associated IBD. The incidence of PSC was not rare compared to reports in adults. PSC should be considered during the management of IBD and vice versa in children.
참고문헌 (23)
- Lindor KD, "ACG Clinical Guideline:primary sclerosing cholangitis", Am J Gastroenterol, 110, pp.646~659 (2015)
- Vergani D, "Autoimmune hepatitis and PSC connection", Clin Liver Dis, 12, pp.187~202 (2008)
- Schrumpf E, "Primary sclerosing cholangitis - the Norwegian experience", Scand J Gastroenterol, 50, pp.781~796 (2015)
- Feldstein AE, "Primary sclerosing cholangitis in children: a long-term follow-up study", Hepatology, 38, pp.210~217 (2003)
- Deneau M, "Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history", Hepatology, 58, pp.1392~1400 (2013)
- Lindström L, "Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis", Dis Colon Rectum, 54, pp.1392~1397 (2011)
- Broomé U, "Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer", Semin Liver Dis, 26, pp.31~41 (2006)
- Kornfeld D, "Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study", Gut, 41, pp.522~525 (1997)
- Sano H, "Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis", J Hepatobiliary Pancreat Sci, 18, pp.154~161 (2011)
- Kaplan GG, "The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis", Am J Gastroenterol, 102, pp.1042~1049 (2007)
- Faubion WA Jr, "Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc", J Pediatr Gastroenterol Nutr, 33, pp.296~300 (2001)
- 정지아, "자가면역성 간염과 담관병증의 중복증후군 (Autoimmune Overlap Syndrome) 1예", Pediatric Gastroenterology, Hepatology & Nutrition, 9(2), pp.269~275 (2006), 대한소아소화기영양학회
- Kim JS, "A case of primary sclerosing cholangitis with ulcerative colitis", J Korean Pediatr Soc, 39, pp.1448~1454 (1996)
- 홍지나, "Autoimmune hepatitis-primary sclerosing cholangitis overlap syndrome in a 10-year-old girl with ulcerative colitis", Korean Journal of Pediatrics, 52(4), pp.504~507 (2009), 대한소아과학회
- Miloh T, "A retrospective single-center review of primary sclerosing cholangitis in children", Clin Gastroenterol Hepatol, 7, pp.239~245 (2009)
- MacCarty RL, "Primary sclerosing cholangitis: findings on cholangiography and pancreatography", Radiology, 149, pp.39~44 (1983)
- Björnsson E, "Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis", Gut, 51, pp.731~735 (2002)
- Levine A, "Pediatric modification of the Montreal classification for inflammatory bowel disease:the Paris classification", Inflamm Bowel Dis, 17, pp.1314~1321 (2011)
- Soetikno RM, "Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis", Gastrointest Endosc, 56, pp.48~54 (2002)
- McDiarmid SV, "Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report", Clin Transpl, pp.119~130 (2003)
- Broomé U, "Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential", Hepatology, 22, pp.1404~1408 (1995)
- Khaderi SA, "Screening for malignancy in primary sclerosing cholangitis (PSC)", Curr Gastroenterol Rep, 17, pp.17~ (2015)
- Farraye FA, "AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease", Gastroenterology, 138, pp.738~745 (2010)